M11.049
Hydroxyapatite deposition disease, unspecified hand
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite Deposition Disease (HADD) is a condition where tiny crystals of hydroxyapatite—a mineral found in bones and teeth—deposit in soft tissues. When these deposits occur in the hand, they can cause pain, swelling, and functional limitations. The specific ICD-10 code M11.049 refers to an unspecified hand affected by this condition. While often seen as a benign and self-limiting disorder, HADD can significantly affect daily activities and comfort depending on the severity and location of the deposits.
Causes & Symptoms
Clinical Causes: Unknown precise causes, but mineral deposits tend to develop due to disturbances in calcium-phosphate metabolism. Repetitive trauma or injury to the hand tissues may contribute to crystal formation. Degenerative conditions or altered blood flow might predispose certain individuals. Genetic predisposition could play a role, although specific hereditary factors are not clearly established. Underlying metabolic or inflammatory diseases might increase susceptibility.
Key Symptoms: Localized pain, especially during movement or pressure. Swelling and tenderness in the affected area of the hand. Reduced range of motion or stiffness in joints or tendons. Palpable lumps or masses felt near joints or tendons. Possible redness or warmth over the affected region.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination and imaging studies. Radiographs (X-rays) are the primary tool, revealing calcified deposits within soft tissues. In some cases, ultrasound or MRI scans may be used to assess the extent of tissue involvement. Laboratory tests are usually not diagnostic but can help rule out other metabolic or inflammatory conditions. A healthcare professional will interpret these findings in conjunction with symptoms to confirm the diagnosis.
Treatment Protocols: Management strategies focus on alleviating symptoms and reducing inflammation. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief. - Rest and immobilization of the affected hand to minimize stress. - Physical therapy to improve mobility and reduce stiffness. - Corticosteroid injections in severe cases to control inflammation. - Extracorporeal shockwave therapy may be considered to help dissolve deposits. - Surgical removal of calcifications, particularly if conservative treatments fail, to restore function and relieve discomfort. It is essential to consult healthcare professionals for an individualized plan based on the extent and impact of the deposits.
Clinical Advice & FAQs
Billing Guidance
Is M11.049 a billable ICD-10 code?
Yes, M11.049 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.049?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified hand and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
